By Ronda Ash, MHLW, CPC, CPMA, CHC, CIHFA, Vice President of Coding
When CMS released the proposed 2027 Medicare Physician Fee Schedule (MPFS) this summer, healthcare organizations had an opportunity to begin evaluating where reimbursement changes could create financial pressure. Now the MPFS Final Rule is here, and the picture is clearer.
The takeaway is not simply that Medicare payment is going down. The impact varies considerably by specialty, service mix, and care setting. Some specialties are expected to see meaningful gains, while others face reductions that could put additional pressure on already-tight margins.
Organizations need to understand where reimbursement is changing and model the potential impact by applying those changes to their own Medicare volume, service and procedure mix, specialties, and sites of service. They also need to make sure coding, documentation, and revenue cycle processes are ready when the new rates take effect January 1.
Final conversion factors add to reimbursement pressure
CMS finalized two MPFS conversion factors for 2027:
- $32.95 for qualifying Advanced Alternative Payment Model (Advanced APM) participants
- $32.63 for clinicians who are not qualifying participants
That represents estimated decreases of approximately 1.83% and 2.31%, respectively, from 2026. They are also lower than the conversion factors CMS proposed this summer. But focusing on the conversion factor alone can give organizations an incomplete picture of their 2027 financial exposure.
Medicare payments reflect multiple components, including physician work, practice expense (PE), and malpractice (MP) relative value units (RVUs). Changes to those RVUs mean the financial impact of the Final Rule is not distributed evenly.
For revenue cycle and finance leaders, the more important question is not simply, How much did the conversion factor change? Instead, it is: What will the combined changes mean for the services our organization provides?
The 2027 changes create clear specialty winners and losers
CMS’s estimated reimbursement changes by provider type and specialty demonstrate how significantly the Final Rule’s impact can vary.
Changes to practice expense RVUs are an especially important driver. These RVUs account for resources such as clinical labor, medical supplies, and equipment used to provide care. That means the conversion factor alone doesn’t tell the full reimbursement story. Changes to how practice expenses are calculated and allocated can result in very different impacts across provider types and specialties.
Some of the largest estimated specialty impacts include:
| Provider type/Specialty | Estimated 2027 reimbursement change | What’s driving the change |
| Clinical social workers | +11% | +3% work RVU, +8% practice expense |
| Clinical psychologists | +9% | +2% work RVU, +7% practice expense |
| Physical/occupational therapy | +3% | +3% practice expense |
| Vascular surgery | +3% | +3% practice expense |
| Interventional radiology | +3% | +3% practice expense |
| Ophthalmology | -3% | Primarily practice expense |
| Dermatology | -4% | Primarily practice expense |
| Hand surgery | -4% | -1% work RVU, -3% practice expense |
| Audiology | -4% | -4% practice expense |
| Otolaryngology | -5% | -1% work RVU, -4% practice expense |
| Orthopedic surgery | -6% | -2% work RVU, -4% practice expense |
| CMS provider type and specialty-level impacts are estimates based on changes in total allowed charges. Actual reimbursement impact will vary based on an organization’s service mix, Medicare volume, site of service and other factors. | ||
Percentage changes don’t tell the entire story. The financial significance also depends on the amount of Medicare reimbursement flowing through a provider type or specialty. A smaller percentage change across a high-volume service line can create substantial financial exposure, making it important for organizations to model the Final Rule against their own service mix rather than relying on national averages.
For multispecialty groups and health systems, organization-wide averages can hide this exposure. Gains in one area may partially offset losses somewhere else, while individual departments or physician groups experience considerably different results.
Practice expense changes deserve particular attention
One of the most consequential pieces of the Final Rule is CMS’s continued revision of PE methodology.
CMS finalized changes to the way indirect practice expenses are allocated and is phasing out portions of the existing indirect practice cost methodology over two years. To ease the transition, CMS also finalized a 5% annual cap on certain practice expense RVU changes resulting from the new methodology and a two-year phaseout of the indirect practice cost index.
Even with these transition provisions, PE changes are driving some of the largest reimbursement shifts for 2027. Organizations should identify the services most affected by practice expense RVU changes and model the impact against their own Medicare volume, service mix, and site of care.
It’s important to pay particular attention to specialties and service lines with significant staffing, equipment, supply, technology, and occupancy costs. Understanding where reimbursement is moving before January 1 gives finance and revenue cycle teams time to adjust forecasts, validate fee schedules, and establish benchmarks for monitoring actual payments in 2027.
Revenue cycle preparation should happen before your first 2027 claim
Understanding the Final Rule is only the first step. Organizations now need to translate policy changes into operational changes by following the steps below:
1. Model your actual reimbursement exposure
Rather than applying an across-the-board percentage to Medicare revenue, model the Final Rule by applying the finalized reimbursement changes to your own service and procedure mix, Medicare volume, specialties, and sites of service.
Focus your analysis on:
- High-volume codes with significant payment changes
- Specialties facing the greatest projected gains or losses
- Differences in reimbursement impact between facility and non-facility settings
- Services affected by changes to work or practice expense RVUs
- Areas where a relatively small percentage change could have a substantial dollar impact because of volume
2. Validate coding and documentation
Review coding, documentation, and charge-capture processes for services with meaningful reimbursement or policy changes and address any gaps that could lead to missed or incorrect reimbursement.
An organization already facing a Medicare payment reduction has even less room for avoidable revenue leakage caused by incorrect coding, incomplete documentation, or missed charges.
3. Update systems and fee schedules
Make sure the correct 2027 Physician Fee Schedule, RVUs, geographic adjustments, and code changes are loaded into applicable systems for January 1.
Billing and payment-posting teams should also understand expected reimbursement so they can distinguish a legitimate 2027 payment change from an underpayment or payer-processing problem.
4. Prepare your teams for the changes
Translate relevant Final Rule changes into clear guidance for the teams responsible for documentation, coding, billing, payment posting, and financial monitoring. Focus education on the changes that directly affect each team rather than overwhelming staff with provisions that don’t apply to their work.
5. Establish an early-warning system
The first few months of the year should be treated as a validation period. Monitor actual reimbursement against expectations to identify payment issues, unexpected trends, or revenue leakage before they become larger problems.
Focus on:
- Expected versus actual allowed amounts
- Payment variance by specialty and service
- Denial trends
- Underpayments
- Modifier utilization
- Code utilization
- Reimbursement by site of service
- Changes in revenue and margin for highly affected service lines
A dashboard that compares expected reimbursement against actual payments can help teams identify problems before they become several months of lost revenue.
Preparation is the best protection against reimbursement pressure
The 2027 Final Rule does not affect every organization in the same way. That may be its most important message.
A specialty projected to gain under the national estimates can still experience reimbursement pressure because of its particular service mix. A health system that appears relatively neutral overall may have individual departments facing material reductions. And an organization expecting a decrease can compound that loss if coding, documentation, payment variance, or denial issues go undetected.
The organizations best positioned for 2027 will be those that move beyond the headline numbers and understand the impact at the level where reimbursement actually occurs: the provider, service, code, and site of care.
With the Final Rule now published and January 1 approaching, preparation should shift from scenario planning to implementation. Model the financial impact, update systems and workflows, educate the teams responsible for documentation and billing, and know what you expect Medicare to pay before the first 2027 claims are submitted.
Protecting reimbursement cannot eliminate every payment reduction in the Final Rule. But it can help ensure organizations do not lose additional revenue because they were unprepared for changes they could see coming.
Health Prime can help your organization prepare for the regulatory changes ahead. To learn more, please send us an email or visit us at hpiinc.com.
As Vice President of Coding at Health Prime, Ronda Ash leverages her deep expertise in healthcare compliance and law to help clients achieve accuracy, efficiency, and peace of mind in their revenue cycle. With a master’s degree in healthcare law (Nova Southeastern University, summa cum laude) and a bachelor’s in business administration (Northwood University, with honors), Ronda ensures coding integrity and regulatory adherence across all Health Prime programs. Her leadership in auditing, compliance, and reimbursement strategy helps clients minimize risk, reduce denials, and optimize financial performance.


